MENU
ELTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Elicio Therapeutics (ELTX) Earnings Date & Reports
Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers... Show more
A.I. Advisor
published Earnings
ELTX is expected to report earnings to fall 2.33% to -41 cents per share on November 12
Q3'26
Est.
$-0.42
Q2'26
Beat
by $0.11
Q1'26
Missed
by $0.04
Q4'25
Beat
by $0.19
Q3'25
Beat
by $0.08
The last earnings report on August 13 showed earnings per share of -43 cents, beating the estimate of -53 cents. With 335.02K shares outstanding, the current market capitalization sits at 50.99M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
451 D Street
Phone
+1 857 209-0050
Employees
33
Web
https://www.elicio.com